Metraipolis › archive › dc_6265f9ebbc76

Combination therapy with anti-PD-1 antibody, radiotherapy, and tyrosine kinase inhibitor for unresectable primary ectopic hepatocellular carcinoma: a case… — Europe PMC PMID:42523995

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42523995
DOI
10.3389/fimmu.2026.1746990
License (as archived)
solo-consultazione
Archived
2026-10-18T07:02:18.592Z
SHA-256 of the archived text
e61661d387d0abb17f3cdff9470e2d49937eac012432cde067b660ff62a3c1c0
Stable URL of this page
https://metraipolis.com/documento/dc_6265f9ebbc76

How to cite

Combination therapy with anti-PD-1 antibody, radiotherapy, and tyrosine kinase inhibitor for unresectable primary ectopic hepatocellular carcinoma: a case… — Europe PMC PMID:42523995 — Europe PMC (en), https://europepmc.org/article/MED/42523995 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6265f9ebbc76 (Metraipolis archive dc_6265f9ebbc76, sha256 e61661d387d0abb17f3cdff9470e2d49937eac012432cde067b660ff62a3c1c0)
BibTeX
@misc{dc6265f9ebbc76,
  title = {Combination therapy with anti-PD-1 antibody, radiotherapy, and tyrosine kinase inhibitor for unresectable primary ectopic hepatocellular carcinoma: a case… — Europe PMC PMID:42523995},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42523995},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6265f9ebbc76; sha256 e61661d387d0abb17f3cdff9470e2d49937eac012432cde067b660ff62a3c1c0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42523995. Agents can read the archived copy with the MCP tool read_document.